|Bid||530.09 x 800|
|Ask||531.63 x 800|
|Day's Range||525.46 - 533.13|
|52 Week Range||401.07 - 533.15|
|Beta (5Y Monthly)||0.76|
|PE Ratio (TTM)||26.78|
|Earnings Date||Jul 28, 2021|
|Forward Dividend & Yield||1.04 (0.20%)|
|Ex-Dividend Date||Sep 14, 2021|
|1y Target Est||552.66|
With vaccine rollouts through Q2, Thermo Fisher's (TMO) Life-Science Solutions segment is likely to have registered top-line contributions from vaccine and therapy production supplies.
The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.
Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.